Tue.Apr 09, 2024

article thumbnail

STAT+: MassMutual is rolling out free genetic testing for members, a dicey area for life insurers

STAT

One of the country’s biggest life insurers is venturing into genetic testing, an area that’s historically been a minefield for that industry, in a purported effort to keep its members alive longer.  MassMutual announced Tuesday that it’s offering many of its 4.2 million policyholders free genetic risk assessments for eight common diseases, like heart disease, type 2 diabetes, and breast cancer.

Diabetes 363
article thumbnail

Biosimilar uptake appears to finally be on the upswing, and Biocon Biologics is betting on the sector’s future

PharmaVoice

Biosimilars promise market competition for branded biologics, which in theory could drive down prices. But so far, winning market share has been a struggle.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

After years of just ‘running, running,’ a crisis led to a lupus diagnosis. Now she connects others 

STAT

Teenagers don’t get arthritis. That’s what Tiffany Peterson kept hearing as that dreadful feeling in her 17-year-old wrists and knees grew excruciating. So she tried to ignore it, popping over-the-counter pain medicines and keeping her head in science textbooks, her hands full in the evening with extracurriculars and a half dozen younger siblings to care for.

355
355
article thumbnail

Pharma’s drumbeat to justify drug prices is at odds with consumer sentiments

PharmaVoice

More than 20% of Americans are forgoing prescription medications due to costs, but the industry continues to fight policy measures.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

STAT+: Biotech startups post strongest financing numbers in two years

STAT

The numbers are in, and biotech startups recently closed out their best fundraising quarter in two years, signaling that the industry downturn may soon be a thing of the past. Venture-backed biopharma companies raised $6.8 billion in the first three months of the year, according to early data compiled by HSBC. That’s the largest amount raised since the first half of 2022.

355
355
article thumbnail

RPS and HEIW partner for prescribing training in Wales

The Pharmacist

A new training programme to support the Pharmacy Independent Prescribing Service (PIPS) in Wales has been announced by the Royal Pharmaceutical Society (RPS) and Health Education and Improvement Wales (HEIW). Written by practicing pharmacist prescribers and general practitioners, the training content will explore conditions that pharmacists practicing as prescribers in the community might be likely […] The post RPS and HEIW partner for prescribing training in Wales appeared first on The Ph

112
112

More Trending

article thumbnail

NHS trust bids to take license for abandoned gene therapy

pharmaphorum

Great Ormond Street Hospital is applying for the license to a gene therapy for rare disease ADA-SCID that was abandoned by a biotech developer on commercial grounds.

Hospitals 119
article thumbnail

STAT+: Big biotech names roll out Seaport Therapeutics, as interest in neuropsychiatric drugs swells

STAT

The team behind Karuna Therapeutics, which was recently snapped up in a multibillion-dollar deal, on Tuesday rolled out another neuropsychiatric-focused biotech, called Seaport Therapeutics.   The new company will be led by Daphne Zohar, the founding CEO of the biotech startup foundry PureTech Health, which helped launch both Karuna and Seaport.

article thumbnail

Commercialising IVDs – The complex path towards access to early diagnosis

pharmaphorum

Navigating the complex path towards commercialising In Vitro Diagnostics (IVDs) can be challenging. Learn more about the intricate process involved in bringing early diagnostic tools to market.

116
116
article thumbnail

Pfizer’s plot to win the RSV vaccine race

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Hello, everyone. Damian here with an update on the biotech market, a look at the future of genome editing, and the evolving definition of “insider trading.

Vaccines 291
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Asda partners with DSP Pharmacy2U

The Pharmacist

Asda supermarket customers can now order prescriptions alongside their groceries online following a partnership between the supermarket and Pharmacy2U. Prescriptions will then be approved by a patient’s GP and checked by Pharmacy2U before being delivered to the customer via a tracked Royal Mail service. Head of pharmacy and superintendent pharmacist at Asda Pharmacy, Faisal Tuddy, […] The post Asda partners with DSP Pharmacy2U appeared first on The Pharmacist.

107
107
article thumbnail

Philips, maker of millions of defective sleep apnea machines, ordered to overhaul manufacturing

STAT

WASHINGTON — The company responsible for a global recall of sleep apnea machines  will be barred from resuming production at U.S. facilities until it meets a number of safety requirements, under a  long-awaited settlement  announced Tuesday by federal officials. Philips will be required to overhaul its manufacturing and quality control systems and hire independent experts to vet the changes, according to a court order announced by the U.S.

282
282
article thumbnail

UK survey finds deep ethnic divisions in cancer diagnosis

pharmaphorum

A UK report has found that people from minority ethnic backgrounds face an average delay of a year between first noticing symptoms and gaining a diagnosis, which is more than twice as long as white people.

111
111
article thumbnail

STAT+: Pharmalittle: We’re reading about biotech startups, Pfizer’s RSV vaccine, and more

STAT

Rise and shine, everyone, another busy day is on the way. We can tell because countless birds are chirping outside our window, the pace of motor vehicles passing by is picking up, and the official mascots are busy foraging for snacks on the official grounds. As for us, we are engaged in the usual ritual of brewing cups of stimulation. Our choice today is orange cream.

Vaccines 244
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

GPhC proposes annual checks of training providers

The Pharmacist

The General Pharmaceutical Council (GPhC) has proposed that it undertakes more regular quality assurance checks of education and training providers amid changes to the pharmacist and pharmacy technician professions. Changes suggested by the pharmacy regulator would include looking into how trainees are learning from other professions – such as student pharmacists undertaking independent prescribing training. […] The post GPhC proposes annual checks of training providers appeared first on T

article thumbnail

Achieving FAIR bacterial identification

European Pharmaceutical Review

Research published in Biosensors reports the strong potential of using 3D printed substrates in bacterial analysis. The study by Childs et al. utilised a rapid 3D printed µbiochamber with a laser-ablated interdigitated electrode. This system was developed for biofilm analysis of Pseudomonas aeruginosa , Acinetobacter baumannii and Bacillus subtilis using electrochemical biological impedance spectroscopy (EBIS) across a four-hour spectrum.

Dosage 98
article thumbnail

US researchers reveal positive results of personalised vaccine for liver cancer

Pharma Times

Hepatocellular carcinoma is one of the leading causes of cancer-related deaths worldwide

Vaccines 133
article thumbnail

Pfizer, with new study results, seeks to bring RSV shot to adults aged 18-59

BioPharma Dive

The company plans to submit the trial data to regulators in a bid to win approval of its vaccine Abrysvo in adults as young as 18 years old.

Vaccines 111
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Culmination Bio and BillionToOne partner to advance cancer diagnosis

Pharma Times

Both will validate the clinical performance of two new diagnostic tests for regulatory submission

126
126
article thumbnail

Harnessing the velocity of biopharmaceutical advances

pharmaphorum

On today's episode of the podcast CEO and co-founder of 908 Devices Kevin Knopp joins as guest, discussing how such acceleration is by virtue of technological advancements, including the buzzword artificial intelligence (AI) and machine learning when it comes to bioprocessing.

112
112
article thumbnail

Strides gets USFDA approval for Fluoxetine Tabs 10 mg and 20 mg

Express Pharma

Strides Pharma Science announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte, Singapore, has received approval for Fluoxetine Tabs 10 mg and 20 mg, from the United States Food & Drug Administration (USFDA). The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD) Prozac Tablets of Eli Lilly.

103
103
article thumbnail

The Top Pharmacy Benefit Managers of 2023: Market Share and Trends for the Biggest Companies—And What’s Ahead

Drug Channels

Three is still the magic number for pharmacy benefit managers (PBMs). For 2023, nearly 80% of all equivalent prescription claims were processed by three companies: the Caremark business of CVS Health, the Express Scripts business of Cigna, and the Optum Rx business of UnitedHealth Group. Read on for Drug Channels Institute’s (DCI’s) latest market share figures, along with a preview of the industry changes that will shift these shares over the next few years.

90
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

DKSH Performance Materials acquires Elite Organic in Malaysia

Express Pharma

DKSH has signed an agreement to acquire Elite Organic Sdn. Bhd. (Elite Organic) in Malaysia. With this transaction, DKSH Performance Materials expands its capabilities in the pharmaceuticals, foods, and nutraceutical markets, and strengthens its position as a leading specialty chemicals and ingredients distributor in Asia Pacific Elite Organic was established in 1995 and provides value-added ingredients and services to the pharma, food, and nutraceutical industries.

101
101
article thumbnail

Ex-Karuna team launch Seaport with $100m for psychiatry meds

pharmaphorum

The team that brought you Karuna, recently sold to Bristol-Myers Squibb for $14 billion, has set up a neuropsychiatry-focused biotech called Seaport Therapeutics

109
109
article thumbnail

Things You Should’ve Learned in Pharmacy School

PioneerRx

Graduating from pharmacy school is no small feat. After years of study and endless rounds of rotations, residencies, and internships, you’re finally able to.

92
article thumbnail

Ubie AI aims to improve diagnosis of rare disease Cushing’s

pharmaphorum

People with Cushing’s syndrome can sometimes take years to get a diagnosis, but a new project hopes to shorten that timeline with the help of artificial intelligence.

104
104
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

PROSEEK study shows no treatment benefit of Vodobatinib in patients with early Parkinson’s Disease

Express Pharma

Sun Pharma Advanced Research Company announced results of interim analysis from the PROSEEK study, a global, randomised, double blind, placebo-controlled Phase 2 study in patients with Early Parkinson’s Disease. PROSEEK compared two doses of Vodobatinib with placebo and enrolled a total of 513 patients from US, Europe and India. The interim analysis was based on data from 442 patients who completed 40 weeks treatment in Part I of the study.

94
article thumbnail

Bayer, Google partner on AI for time-pressed radiologists

pharmaphorum

Bayer enlists the aid of Google Cloud to develop its AI platform for radiologists, adding genAI capabilities

115
115
article thumbnail

Can the Andaman7 transform patient engagement and communication with AI-enhanced health record update?

Outsourcing Pharma

Andaman7, a free healthcare app aiming to revolutionize patient engagement and streamline communication between patients and researchers, has unveiled its latest update, Andaman7 version 5, featuring advanced artificial intelligence (AI) capabilities.

article thumbnail

NHSE plans to ‘grow patient volumes’ across pharmacy services

The Pharmacist

NHS England (NHSE) aims to increase the number of patients accessing Pharmacy First each month by hundreds of thousands by March 2025, it announced today. And it has set targets for tens of thousands more contraception and blood pressure check consultations to be delivered monthly by community pharmacies over the next year. The commissioner also […] The post NHSE plans to ‘grow patient volumes’ across pharmacy services appeared first on The Pharmacist.

article thumbnail

FDA greenlights Prenosis' AI solution for sepsis diagnosis: is this a paradigm shift in healthcare?

Outsourcing Pharma

In a landmark development poised to reshape the landscape of medical diagnostics, the U.S. Food and Drug Administration (FDA) has officially sanctioned Prenosis' pioneering artificial intelligence (AI) tool designed for the early detection of sepsis.

78